title: [Homocysteine and venous thromboembolism].
abstract: Congenital homocysteinuria is a rare inherited metabolic disorder with early onset atherosclerosis and arterial and venous trombosis. Moderate hyperhomocysteinemia is more frequently encountered and is recognized as an independent cardiovascular risk factor. Several case-control studies demonstrate an association between venous thromboembolism and moderate hyperhomocysteinemia. A patient with moderate hyperhomocysteinemia has a 2-3 relative risk of developing an episode of venous thromboembolism. The occurrence of mild hyperhomocysteinemia in heterozygotes for the mutation of Leiden factor V involves a 10-fold increase in the risk of venous thromboembolism. The biochemical mechanism by which homocysteine may promote thrombosis is not fully recognized. Homocysteine inhibits the expression of thrombomodulin, the thrombin cofactor responsible for protein C activation, and inhibits antithrombin-III binding. Treatment with folic acid reduces the plasma level of homocysteinemia, but no study has demonstrated its efficacy in reducing the incidence of venous thromboembolism or atherosclerosis. Hyperhomocysteinemia should be included in the screening of abnormalities of hemostasis and thrombosis in patients with idiopathic thromboembolism, and mild hyperhomocysteinemia may justify a trial of folic acid.
authors.affiliation: Division des maladies vasculaires et de l'hypertension, Département de médecine interne, Centre hospitalier et universitaire vaudois, Lausanne.
authors.forename: C
authors.initials: C
authors.lastname: Monnerat
authors.forename: D
authors.initials: D
authors.lastname: Hayoz
mesh_terms: D000293:Adolescent; D000328:Adult; D000592:Amino Acid Metabolism, Inborn Errors / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006580:Genetic Carrier Screening; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012306:Risk; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D013924:Thrombophlebitis / Q000097:blood / Q000188:drug therapy / Q000235:genetics*
chemical_list: D006710:Homocysteine; D005492:Folic Acid